General Opportunity at Mytos (London, United Kingdom)
Mytos· London, United Kingdom·
Role details
Job description
About Us:
You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you’ll unleash scientists, accelerate their research and help get cures to patients sooner.
We’ve developed machines to fully automates human cell production - one of the most painful but important processes in biology. Cells are used to discover and develop new drugs, and now they're being used to cure cancer too. Mytos has the potential to impact cure development across the board.
We're live in multibillion dollar biotechs on both coasts of the US, and just raised $19m to expand into the market faster, and accelerate our development!
We’ve assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. You can learn more about your potential Mytos teammates here: Team
Mytos is backed by Y Combinator, the most successful startup program in the world which produced companies such as AirBnb, Dropbox, and Ginkgo Bioworks.
What we're looking for
- Smart people - even if this is just the start of their career (would be their first job)
- Track record of solving hard challenges, whether technical or non-technical
- Low ego, high curiosity
Why work at Mytos
- Mission-driven impact: Directly work on curing Parkinson’s, blindness, and spinal cord injuries at scale — a rare combination of deep tech and patient impact.
- Culture & team: Rated 4.5/5 on employer review platforms (Culture: 4.4, Career: 4.6). Team includes engineers from Dyson, Autodesk, and Matic Robots alongside Nature-published scientists.
- Work location: On-site in London (HQ at 80 Wood Lane) with additional offices in Newark, California and Billingstad, Norway.
- Growth opportunity: Early-stage company (27 people) with clear trajectory to clinical manufacturing — offers outsized ownership and impact for early hires.
- Perks & environment: Fast-paced startup environment; cross-disciplinary collaboration between hardware, software, and biology teams; close ties to Y Combinator and top-tier biotech investors.